Fluorescence in situ hybridization rapidly detects three different pathogenic bacteria in urinary tract infection samples

Journal of Microbiological Methods

Volumn 83, Issue 2, 2010, Pages 175-178

  Wu, Qing ^a   Li, Yan ^a   Wang, Ming ^a   Pan, Xiao P ^a   Tang, Yong F ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Bacteria; Fluorescence in situ hybridization; Rapid detection; Urinary tract infection

Indexed keywords

RNA 16S;

ACCURACY; ARTICLE; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FLUORESCENCE IN SITU HYBRIDIZATION; INTERMETHOD COMPARISON; NONHUMAN; OLIGONUCLEOTIDE PROBE; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; URINARY TRACT INFECTION; URINE CULTURE;

BACTERIOLOGICAL TECHNIQUES; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; OLIGONUCLEOTIDE PROBES; RNA, RIBOSOMAL; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCUS AUREUS; URINARY TRACT INFECTIONS;

BACTERIA (MICROORGANISMS); ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; STAPHYLOCOCCUS AUREUS;

EID: 77957866254     PISSN: 01677012     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mimet.2010.08.015     Document Type: Article

References (20)

1. Abbasi I.A., Hess L.W., Johnson T.R., McFadden E., Chernow B. Leukocyte esterase activity in the rapid detection of urinary tract and lower genital tract infections in obstetric patients. Am. J. Perinatol. 1985, 2:311-313.
2. Abdou M.A. Urinary tract infections. Sensitivity and specificity of previous screening methods (author's transl). MMW Munch. Med. Wochenschr. 1977, 119:837-840.
3. Amann R.I., Krumholz L., Stahl D.A. Fluorescent-oligonucleotide probing of whole cells for determinative, phylogenetic, and environmental studies in microbiology. J. Bacteriol. 1990, 172:762-770.
4. Bertaux J., Gloger U., Schmid M., Hartmann A., Scheu S. Routine fluorescence in situ hybridization in soil. J. Microbiol. Methods 2007, 69:451-460.
5. Bouza E., San Juan R., Munoz P., Voss A., Kluytmans J. A European perspective on nosocomial urinary tract infections I. Report on the microbiology workload, etiology and antimicrobial susceptibility (ESGNI-003 study). European Study Group on Nosocomial Infections. Clin. Microbiol. Infect. 2001, 7:523-531.
6. Clement S., Young J., Munday E. Comparison of a urine chemistry analyser and microscopy, culture and sensitivity results to detect the presence of urinary tract infections in an elective orthopaedic population. Contemp. Nurse 2004, 17:89-94.
7. Davis T.E., Fuller D.D., Aeschleman E.C. Rapid, direct identification of Staphylococcus aureus and Streptococcus pneumoniae from blood cultures using commercial immunologic kits and modified conventional tests. Diagn. Microbiol. Infect. Dis. 1992, 15:295-300.
8. DeLong E.F., Wickham G.S., Pace N.R. Phylogenetic stains: ribosomal RNA-based probes for the identification of single cells. Science 1989, 243:1360-1363.
9. Foxman B., Brown P. Epidemiology of urinary tract infections: transmission and risk factors, incidence, and costs. Infect. Dis. Clin. North Am. 2003, 17:227-241.
10. Foxman B., Barlow R., D'Arcy H., Gillespie B., Sobel J.D. Urinary tract infection: self-reported incidence and associated costs. Ann. Epidemiol. 2000, 10:509-515.
11. Fuchs B.M., Wallner G., Beisker W., Schwippl I., Ludwig W., Amann R. Flow cytometric analysis of the in situ accessibility of Escherichia coli 16S rRNA for fluorescently labeled oligonucleotide probes. Appl. Environ. Microbiol. 1998, 64:4973-4982.
12. Hummers-Pradier E., Kochen M.M. Urinary tract infections in adult general practice patients. Br. J. Gen. Pract. 2002, 52:752-761.
13. Kempf V.A., Trebesius K., Autenrieth I.B. Fluorescent in situ hybridization allows rapid identification of microorganisms in blood cultures. J. Clin. Microbiol. 2000, 38:830-838.
14. Peters R.P., Savelkoul P.H., Simoons-Smit A.M., Danner S.A., Vandenbroucke-Grauls C.M., van Agtmael M.A. Faster identification of pathogens in positive blood cultures by fluorescence in situ hybridization in routine practice. J. Clin. Microbiol. 2006, 44:119-123.
15. Regnault B., Martin-Delautre S., Lejay-Collin M., Lefevre M., Grimont P.A. Oligonucleotide probe for the visualization of Escherichia coli/Escherichia fergusonii cells by in situ hybridization: specificity and potential applications. Res. Microbiol. 2000, 151:521-533.
16. Wagenlehner F.M., Naber K.G., Weidner W. Rational antibiotic therapy of urinary tract infections. Med. Monatsschr. Pharm. 2008, 31:385-390. quiz 391-382.
17. Wagenlehner F.M., Pilatz A., Naber K.G., Weidner W. Therapeutic challenges of urosepsis. Eur. J. Clin. Invest. 2008, 38(Suppl 2):45-49.
18. White A.C., Atmar R.L., Wilson J., Cate T.R., Stager C.E., Greenberg S.B. Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities, and clinical outcomes. Clin. Infect. Dis. 1997, 25:230-239.
19. Yamamoto Y. PCR in diagnosis of infection: detection of bacteria in cerebrospinal fluids. Clin. Diagn. Lab. Immunol. 2002, 9:508-514.
20. Zaman Z., Roggeman S., Verhaegen J. Unsatisfactory performance of flow cytometer UF-100 and urine strips in predicting outcome of urine cultures. J. Clin. Microbiol. 2001, 39:4169-4171.